BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6248289)

  • 1. A radioreceptor assay for propranolol and 4-hydroxypropranolol.
    Rochester CL; Gammon DE; Shane E; Bilezikian JP
    Clin Pharmacol Ther; 1980 Jul; 28(1):32-9. PubMed ID: 6248289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A radioreceptor assay in which iodocyanopindolol is used to determine propranolol and its active metabolites in unextracted serum or plasma.
    Elkins RP; Kelly JF; Rosenberg BJ
    Clin Chem; 1986 Jan; 32(1 Pt 1):180-3. PubMed ID: 2866853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereoselective high-performance liquid chromatography determination of propranolol and 4-hydroxypropranolol in human plasma after pre-column derivatization.
    Wu ST; Chang YP; Gee WL; Benet LZ; Lin ET
    J Chromatogr B Biomed Sci Appl; 1997 Apr; 692(1):133-40. PubMed ID: 9187392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Routine methods in toxicology and therapeutic drug monitoring by high-performance liquid chromatography. IV. A rapid microscale method for determination of propranolol and 4-hydroxypropranolol in plasma.
    Sood SP; Green VI; Mason RP
    Ther Drug Monit; 1988; 10(2):224-30. PubMed ID: 3381242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does fluorescent analogue of propranolol, 9-amino-acridine-propranolol, binding sites really show the beta-adrenoreceptors?
    Murakami E; Shiosaka S; Tohyama M
    Cell Mol Biol Incl Cyto Enzymol; 1981; 27(2-3):133-7. PubMed ID: 6271398
    [No Abstract]   [Full Text] [Related]  

  • 6. High-performance liquid chromatographic determination of propranolol and 4-hydroxypropranolol in serum.
    Abdel-Hamid ME
    J Clin Pharm Ther; 1988 Jun; 13(3):183-9. PubMed ID: 3209625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous determination of propranolol and 4-hydroxypropranolol in plasma by mass fragmentography.
    Walle T; Morrison J; Walle K; Conradi E
    J Chromatogr; 1975 Nov; 114(2):351-9. PubMed ID: 417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined high-performance liquid chromatographic procedure for measuring 4-hydroxypropranolol and propranolol in plasma: pharmacokinetic measurements following conventional and slow-release propranolol administration.
    Drummer OH; McNeil J; Pritchard E; Louis WJ
    J Pharm Sci; 1981 Sep; 70(9):1030-2. PubMed ID: 6101148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of propranolol and 4-hydroxypropranolol in human plasma by high-performance liquid chromatography.
    Fu CW; Mason WD
    Analyst; 1989 Oct; 114(10):1219-23. PubMed ID: 2619067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of 4'-hydroxypropranolol sulfate, a major non-beta-blocking propranolol metabolite in man.
    Oatis JE; Walle T; Daniell HB; Gaffney TE; Knapp DR
    J Med Chem; 1985 Jun; 28(6):822-4. PubMed ID: 2861287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-performance liquid chromatographic assay for the derivatized enantiomers of propranolol and 4-hydroxypropranolol in human plasma.
    Miller RB
    J Pharm Biomed Anal; 1991; 9(10-12):953-8. PubMed ID: 1822218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-performance liquid chromatographic determination of propranolol and 4-hydroxypropranolol in plasma.
    Rosseel MT; Bogaert MG
    J Pharm Sci; 1981 Jun; 70(6):688-9. PubMed ID: 7252820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a radioreceptor assay for beta-adrenoceptor antagonists in plasma.
    Barnett DB; Batta M; Davies B; Nahorski SR
    Eur J Clin Pharmacol; 1980 May; 17(5):349-54. PubMed ID: 6106550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct high-performance liquid chromatographic determination in urine of the enantiomers of propranolol and its major basic metabolite 4-hydroxypropranolol.
    Herring VL; Johnson JA
    J Chromatogr; 1993 Feb; 612(2):215-21. PubMed ID: 8468379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of plasma on human erythrocyte beta-adrenergic receptors.
    Sager G; Jacobsen S
    Biochem Pharmacol; 1985 Oct; 34(20):3767-71. PubMed ID: 2996559
    [No Abstract]   [Full Text] [Related]  

  • 16. Measurement of propranolol, 4-hydroxypropranolol and propranolol glycol in human plasma.
    Schneck DW; Pritchard JF; Hayes AH
    Res Commun Chem Pathol Pharmacol; 1979 Apr; 24(1):3-12. PubMed ID: 432438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-pressure liquid chromatographic method for the simultaneous quantitative analysis of propranolol and 4-hydroxypropranolol in plasma.
    Nation RL; Peng GW; Chiou WL
    J Chromatogr; 1978 May; 145(3):429-36. PubMed ID: 659528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacology of 4-hydroxypropranolol, a metabolite of propranolol.
    Fitzgerald JD; O'Donnell SR
    Br J Pharmacol; 1971 Sep; 43(1):222-35. PubMed ID: 4400184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma concentrations of propranolol and 4-hydroxypropranolol during chronic oral propranolol therapy.
    Wong L; Nation RL; Chiou WL; Mehta PK
    Br J Clin Pharmacol; 1979 Aug; 8(2):163-7. PubMed ID: 486291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluorescence studies of the beta-adrenergic receptor topology.
    Cherksey BD; Murphy RB; Zadunaisky JA
    Biochemistry; 1981 Jul; 20(15):4278-83. PubMed ID: 6269586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.